Literature DB >> 29253844

Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population.

Quan Lan J Lew1, John C Allen2, Francis Nguyen3, Ngiap Chuan Tan1,3,4, Tazeen H Jafar3,5,6,7.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a major global public health challenge. We investigated determinants of CKD and their clinical utility in an ethnically diverse Southeast Asian population.
METHODS: Electronic health records (EHR) of adults ≥40 years who visited any one of 4 government polyclinics in Singapore from January 1, 2012 to -December 31, 2015 were analyzed. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2 or 1+ dipstick proteinuria excretion, based on 2 measurements ≥3 months apart. CKD-associated factors and their clinical utility for predicting odds of CKD were investigated using multiple logistic regression analysis.
RESULTS: Based on the study criteria, 25.9% (95% CI 25.6-26.2) of the 88,765 eligible study individuals had CKD. The factors (OR and 95% CI) independently associated with CKD were older age ≥65 years (2.54 [2.44-2.64] vs. ≤65 years), respectively; men (1.13 [1.09-1.18]); Malay (1.27 [1.20-1.33]) and Indian (0.77 [0.71-0.83]) vs. Chinese ethnicity; overweight (body mass index [BMI] ≥27.5 kg/m2; 1.10 [1.04-1.16]) vs. normal weight (BMI 18 to <23 kg/m2); government (1.22 [1.15-1.31]) vs. private housing; and with hypertension (3.32 [3.09-3.56]), diabetes (6.93 [6.67-7.20]) or stroke (1.46 [1.36-1.56]) vs. without each co-morbidity, respectively. The area under the receiver operating characteristic curve (95% CI) for the model to predict the probability of CKD using hypertension, diabetes, and age was 0.808 (0.805-0.811). Only 28.5% (27.9-29.1%) of individuals with CKD had physician documentation of their CKD status. However, documentation of CKD status was associated with age ≥65 years (1.11 [1.04-1.20] vs. <65 years), men (1.35 [1.26-1.44]) vs. women, with vs. without hypertension (1.24 [1.07-1.44]), Indian (0.80 [0.69-0.92]) compared to Chinese ethnicity, ever smokers (0.89 [0.81-0.99]) vs. non-smokers, and those with vs. without stroke (0.83 [0.75-0.93]).
CONCLUSIONS: CKD prevalence in our Southeast Asian population is high and under-documented even in high-risk patients. Our findings highlight factors associated with CKD, and the predictive value of hypertension, diabetes, and advancing age as EHR-based screening targets for CKD. Our results also suggest that complementary educational efforts will be needed to increase physician detection and optimize the management of CKD, especially in high risk and marginalized groups across all clinics in Singapore, and possibly in the region.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic kidney disease; Diabetes; Hypertension; Southeast Asia

Mesh:

Year:  2017        PMID: 29253844     DOI: 10.1159/000485110

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease.

Authors:  Hongzhen Zhong; Tianbiao Zhou; Hongyan Li; Zhiqing Zhong
Journal:  Drug Des Devel Ther       Date:  2018-09-18       Impact factor: 4.162

2.  Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease.

Authors:  Cynthia C Lim; Miao Li Chee; Ching-Yu Cheng; Jia Liang Kwek; Majorie Foo; Tien Yin Wong; Charumathi Sabanayagam
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

3.  Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.

Authors:  Yeli Wang; Francis Ngoc Hoang Long Nguyen; John C Allen; Jasmine Quan Lan Lew; Ngiap Chuan Tan; Tazeen H Jafar
Journal:  BMC Nephrol       Date:  2019-12-04       Impact factor: 2.388

4.  Prevalence and factors associated with chronic kidney disease among medical inpatients at the Kenyatta National Hospital, Kenya, 2018: a cross-sectional study.

Authors:  Valerian Mwenda; Jane Githuku; Gladwell Gathecha; Benjamin Maranga Wambugu; Zeinab Gura Roka; Willis Owino Ong'or
Journal:  Pan Afr Med J       Date:  2019-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.